IRON as reported
- Net Income
- −$246M
Net Income · +69% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- −$198M
Free Cash Flow · +46% year on year · trailing twelve months to Q2 2026
- EPS
- −$6.58
EPS · +47% year on year · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net Income | −$246M | +69% | Q2 2026 |
| EPS | −$6.58 | +47% | Q2 2026 |
| ROE | −33% | n/a | Q2 2026 |
| ROA | −30% | n/a | Q2 2026 |
| ROIC | 1304% | n/a | Q2 2026 |
| Free Cash Flow | −$198M | +46% | Q2 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Disc Medicine, Inc. (IRON) - Net IncomeNet IncomeDisc Medicine, Inc. (IRON)